Paul W Harms
Clinical Professor of Pathology
Clinical Professor of Dermatology
Medical School
[email protected]
Available to mentor
Paul W Harms
Clinical Professor
Manage Your Profile
About
Dr. Paul Harms is a board-certified pathologist and dermatopathologist.
Center Memberships
-
Center MemberRogel Cancer Center
Research Overview
Dr. Harms has interested in molecular markers and mechanisms of cutaneous diseases, especially cutaneous neoplasia. His work has advanced understanding of the genomic drivers of multiple skin malignancies, especially Merkel cell carcinoma.
Recent Publications
-
Jiang R, Kirma J, Fox J, Xing X, Wang J, Sarkar MK, Bogle R, Do T, Coon A, Cole C, Plazyo O, Rew JE, Zhang H, Kahlenberg JM, Billi AC, Bachelez H, Tsoi LC, Harms PW, Shao S, Chen X, Gudjonsson JE. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleDynamic neutrophil-keratinocyte communication network centered on IL-36/TNFSF15 responses characterizes inflammatory responses in generalized pustular psoriasis
DOI:10.1038/s41467-025-67917-9 PMID: 41436466 -
Jiang R, Bogle R, Xing X, Kirma J, Fox J, Harms PW, Do T, Billi AC, Kahlenberg JM, Modlin RL, Teles R, West J, Mangold A, Zhang H, Schneider MA, Bruno S, Roediger B, Martiny-Baron G, Tsoi LC, Hacini-Rachinel F, Röhn TA, Gudjonsson JE. Nat Commun, 2026 Mar 14;Journal ArticleSingle-cell and spatial profiling reveal cDC2A-CXCL13+CD8+ T-epithelial cell crosstalk and cytotoxicity through TNFRSF9 in cutaneous and mucosal lichen planus.
DOI:10.1038/s41467-026-70506-z PMID: 41832141 -
Wiedemeyer K, Harms P, Bresler S. Laboratory Investigation, 2026 Mar 24; 106 (3): 104689Journal Article406 Adverse Outcome in Merkel Cell Carcinoma with Microsatellitosis - A Clinicopathologic Study Of 25 Cases
DOI:10.1016/j.labinv.2025.104689 -
Sousa-Squiavinato ACM, Billington J, Del Castillo Velasco-Herrera M, Wong K, Cheema S, Vermes I, Anderson E, Vasisht A, Harms PW, Clarke EL, Merchant W, Weigelt MA, Billings SD, Monteagudo C, Alomari AK, Arends MJ, Wiedemeyer K, Ferreira I, Brenn T, van der Weyden L, Adams DJ. British Journal of Dermatology, 2026 Mar 1; 194 (3): 593 - 595.Journal ArticleCellular neurothekeoma is driven by copy number deletions, providing potential diagnostic and therapeutic avenues
DOI:10.1093/bjd/ljaf487 PMID: 41365817 -
Liv T, Touzé A, Schrama D, Guyétant S, Samimi M, Tetzlaff MT, Wood BA, Harms PW, Kervarrec T. Histopathology, 2026 Mar 1; 88 (4): 769 - 789.Journal ArticleRB1 inactivation in cutaneous carcinomas
DOI:10.1111/his.70056 PMID: 41395640 -
Pedersen EA, Grachtchouk M, Harms PW, Furgal AKC, Wilbert D, Hoover A, Hodgson DV, Fiehler K, Alam A, Lingam N, Wong SY, Verhaegen ME, Dlugosz AA. Jid Innovations, 2026 Mar 1; 6 (2):Journal ArticleSpatially controlled induction and regression of basal cell carcinoma, visualized by serial imaging in young and old mice
DOI:10.1016/j.xjidi.2025.100441 -
Velez K, Breglio K, Petroze RT, Warren SJ, Harms PW, Harms KL, Plotzke JM. Journal of Cutaneous Pathology, 2026 Feb 1; 53 (2): 153 - 157.Journal ArticleNodal Cellular Blue Nevus in Sentinel Lymph Node Biopsy: A Case Report With Emphasis on Avoiding Misdiagnosis of This Important Mimicker of Metastatic Melanoma
DOI:10.1111/cup.70006 PMID: 41183565 -
Harms PW. Modern Pathology, 2026 Jan 1; 39 (1):Journal ArticleCD38 Expression and 6q/9q Codeletion: Diagnostic Markers for Primary Cutaneous Cribriform Tumor
DOI:10.1016/j.modpat.2025.100927 PMID: 41297323
